Hossein Bakhtiari-Dovvombaygi

Mr. Hossein Bakhtiari-Dovvombaygi

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 March 2025 in BMC Nursing
Verified
Journal Article
Open access
PDF file
Amir Mohamad NazariAmir Mohamad Nazari
Amir Mohamad Nazari
HBHossein Bakhtiari-Dovvombaygi
Hossein Bakhtiari-Dovvombaygi
FBFariba Borhani
Fariba Borhani
AAAbbas Abbaszadeh
Abbas Abbaszadeh
MGMostafa Gholami
Mostafa Gholami
SRSamin Bakhshalizadeh Rashti
Samin Bakhshalizadeh Rashti
In their daily practice, nurses face difficult ethical challenges. To ensure the provision of humane care, it is imperative for nurses to be sensitive to ethical dilemmas. The main objective of this study was to investigate the correlation between ethical sensitivity, caring behavior, and the overall quality of care that is being delivered by nurses. In accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, we conducted a thorough search of the PubMed, Web of Science, Scopus, and ProQuest databases to ensure a comprehensive review. Our research focused on analyzing studies that met the inclusion criteria, which included publications from the year 2000 up until the end of August 2024. These studies were selected based on their investigation of the relationship between ethical sensitivity, caring behavior, and the quality of care provided by nurses. The exclusion criteria for this study included not having access to full-text articles, articles written in languages other than Persian and English, protocol studies, case studies, brief reports, reviews, and qualitative studies. The assessment of quality was performed using the JBI tool. Out of the 2957 records that were retrieved, only 11 studies were ultimately selected and included in this review. Among these included studies, 6 specifically focused on examining the correlation between ethical sensitivity and caring behavior displayed by nurses, while the remaining 5 studies focused on exploring the relationship between ethical sensitivity and the quality of care in nurses. The results of this study discovered that ethical sensitivity has the potential to significantly influence the caring behavior and quality of care provided by nurses. The quality of nursing care can be influenced by ethical sensitivity; therefore, it is advisable to arrange regular training programs in clinical settings to educate nurses on ethical principles, with the goal of fostering their ethical sensitivity.

19 November 2024 in BMC Neurology
Verified
Journal Article
Open access
PDF file
ANAmirreza Nasirzadeh
Amirreza Nasirzadeh
MMMohammad Mohammadi
Mohammad Mohammadi
MBMelika Arab Bafrani
Melika Arab Bafrani
AMAynaz Mohammadi
Aynaz Mohammadi
HBHossein Bakhtiari-Dovvombaygi
Hossein Bakhtiari-Dovvombaygi
Multiple sclerosis (MS) is a chronic autoimmune disorder affecting the central nervous system, leading to a range of symptoms that impact physical, psychiatric, and cognitive functions. Cognitive dysfunction is prevalent among patients with MS (pwMS), affecting at least 65% of patients, and includes deficits in processing speed, attention, learning, memory, and executive function. Despite the significant impact on daily life, cognitive impairment in MS patients is often underrecognized in clinical settings. This systematic review and meta-analysis aimed to evaluate cognitive function using the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS) battery among pwMS patients and healthy controls (HCs). A comprehensive search of the Web of Science, PubMed, Scopus, and Cochrane Library databases was conducted on January 2024 following the PRISMA guidelines. Eligible studies included peer-reviewed research assessing the validity of the MACFIMS in adult MS patients. Data extraction and quality assessment were performed using standardized tools, and statistical analyses were conducted using R4.2.3. Eight studies met the inclusion criteria, including a total of 1,481 pwMS and 1,072 HCs. The meta-analysis revealed significant cognitive deficits in pwMS patients compared to HCs across all the MACFIMS subtests, including language, spatial processing, new learning and memory, processing speed, and executive function. Processing speed and working memory were the most affected domains, with 36% of pwMS showing impairment on the Symbol Digit Modalities Test (SDMT). Subgroup analyses indicated that the Expanded Disability Status Scale (EDSS) score significantly influenced cognitive impairment, while disease duration had a limited impact. The MACFIMS effectively discriminates between pwMS patients and HCs, demonstrating its validity as a comprehensive cognitive assessment tool for MS. Routine cognitive screening, particularly for processing speed and working memory, is crucial for early detection and intervention. Future research should focus on the sensitivity and specificity of the MACFIMS across diverse MS subtypes and cultural contexts to enhance its global applicability in clinical practice.

30 June 2021 in HIV & AIDS Review
Verified
Journal Article
Closed access
PDF file
MSMohammad Sarmadi
Mohammad Sarmadi
AGAbbas Ghodrati-Torbati
Abbas Ghodrati-Torbati
AGAkram Gazerani
Akram Gazerani
HYHamideh Yaghoobi
Hamideh Yaghoobi
HBHossein Bakhtiari-Dovvombaygi
Hossein Bakhtiari-Dovvombaygi
Introduction The coronavirus disease 2019 (COVID-19) has become the greatest critical healthcare concern in 2020. The present study investigated the correlation between COVID-19 distribution and the prevalence of human immunodeficiency virus/acquired immunodeficiency syndrome...

2 January 2025 in Topics in Stroke Rehabilitation
Verified
Journal Article
Closed access
HBHossein Bakhtiari-Dovvombaygi
Hossein Bakhtiari-Dovvombaygi
ZRZahra Rahmaty
Zahra Rahmaty
MRMaryam Rassouli
Maryam Rassouli
VZVahid Zamanzadeh
Vahid Zamanzadeh
KPKosar Pourhasan
Kosar Pourhasan
AAAbbas Abbaszadeh
Abbas Abbaszadeh
The successful transition of stroke patients from hospital to home relies on the preparedness of caregivers. Assessing this preparedness is crucial, but existing tools need adaptation and validation for Iranian caregivers. This study aimed to translate, culturally adapt, and validate the Persian version of the "Preparedness Assessment for the Transition Home After Stroke" (PATH-s) for use among Iranian caregivers of stroke survivors. It also assessed the association of patient and caregivers' characteristic association with the final PATH score. The PATH-s was translated and culturally adapted using the Backward-Forward translation method and expert consultations. Face and content validity were ensured through input from both caregivers and experts. Participants were recruited from two referral hospitals in Tehran, Iran. The sample consisted of 386 caregivers, 74.4% female with a mean age of 47.18 years (SD = 12.2). Construct validity was assessed using Exploratory and Confirmatory Factor Analyses (EFA and CFA). Convergent validity was evaluated through the correlation with Zarit Burden Interview scores. Reliability was tested through internal consistency (Cronbach's alpha) and test-retest reliability (Intraclass Correlation Coefficient, ICC). The factor analysis revealed a seven-factor structure with robust fit indices (CFI = 0.92, TLI = 0.90, RMSEA = 0.068, SRMR = 0.074). Convergent validity was supported by a significant negative correlation with the Zarit Burden Interview (r = -0.27, p < 0.001). Reliability analysis showed good internal consistency (Cronbach's alpha = 0.84) and excellent test-retest reliability (ICC = 0.96). The Persian version of PATH-s is a valid and reliable tool for assessing caregiver preparedness in Iran. Its use can improve patient outcomes and caregiver support during hospital-to-home transitions.

11 December 2023 in Thalassemia Reports
Verified
Journal Article
Open access
PDF file
AAAily Aliasgharian
Aily Aliasgharian
HKHossein Karami
Hossein Karami
MZmohammad zahedi
mohammad zahedi
RJReza Jahanshahi
Reza Jahanshahi
HBHossein Bakhtiari-Dovvombaygi
Hossein Bakhtiari-Dovvombaygi
HDHadi Darvishi-Khezri
Hadi Darvishi-Khezri
Background and aim: We conducted a review to determine the efficacy of amlodipine alongside iron chelators on serum ferritin levels and liver T2-weighted magnetic resonance imaging (MRI T2*) in β-thalassemia patients. Methods: Systematic search was conducted in multiple databases, including Web of Science, PubMed, Scopus, Embase, Cochrane Library, ClinicalTrials.gov, the Iranian Registry of Clinical Trials (IRCT), ProQuest, OpenGrey, and Web of Science Conference Proceedings Citation Index. The search was closed in January 2023. Primary outcomes were comprised of liver MRI T2* (millisecond (msec)) and serum ferritin levels (ng/mL). Results: Seven studies (n = 227) were included in the study. The pooled Cohen’s d for serum ferritin was estimated at −0.46, 95% confidence interval (CI) −1.11 to 0.19 and p = 0.16 (I2 86.23%, p < 0.0001). The pooled mean difference for serum ferritin was −366.44 ng/mL, 95% CI −844.94 to 112.05, and p = 0.13 (I2 81.63%, p < 0.0001). After a meta-regression based on the length of using amlodipine, a coefficient for the mean difference was also −23.23 ng/mL and 95% CI −155.21 to 108.75. The coefficient obtained from a meta-regression as per the amlodipine dose at 5 mg/day than 2.5 to 5 mg/day anchored at −323.49 ng/mL and 95% CI −826.14 to 1473.12. A meta-regression according to the baseline values of serum ferritin discovered a coefficient of 1.25 ng/mL and 95% CI 0.15 to 2.35. Based on two included studies (n = 96), the overall Cohen’s d for liver MRI T2* was 2.069, 95% CI −0.896 to 5.035, and p = 0.17 (I2 96.31%, p< 0.0001). The synthesized mean difference for liver MRI T2* was 8.76 msec, 95% CI −4.16 to 21.67, and p = 0.18 (I2 98.38%, p < 0.000). Conclusion: At a very low level of evidence, probably using amlodipine at a dose of 2.5 to 5 mg a day, up to a year, alongside iron chelators slightly decreases serum ferritin levels in iron-overloaded thalassemia cases by nearly 366 ng/mL (23 ng/mL per month). The liver MRI T2* might also rise to 8.76 msec upon co-therapy with amlodipine.